Janssen Search
Search results
Value of Medicines
How We Think About Value, Access and Pricing We advance healthy outcomes by ensuring healthcare professionals and patients have access to the information, programs and support they need to achieve the best results possible. At Janssen, we seek medical ...
Chronic Infections
Article Type: Infectious Diseases & Vaccines Chronic Infections HIV The global HIV epidemic began more than 40 years ago. There's been significant progress in tackling this virus since then, but HIV remains one of the most significant ...
Story – Cork Lower Harbour Energy Group
Cork Lower Harbour Energy Group In 2008 Janssen began collaborating with DePuy Synthes, GlaxoSmithKline (GSK) and Novartis to form the Cork Lower Harbour Energy Group (CLHEG), a unique industry collaboration focused on developing a green solution to ...
Story – Mental Health Initiatives
Developing Solutions and Creating Access for People With Mental Illness From research to real-world solutions, Janssen has a legacy of developing treatments for mental illnesses. For more than 50 years, our unwavering commitment to mental health has led ...
Antonio Ferreira
Antonio Ferreira is International Vice President, Janssen Latin America, and a member of the Johnson & Johnson Pharmaceuticals Group Operating Committee. He assumed this position in 2011. In this role, Antonio is responsible for the strategic ...
Infectious Disease Treatment Development
Development Article Type: Infectious Diseases & Vaccines Exploring the potential of multiple treatment combinations to make a difference in patients' lives The Janssen Infectious Diseases & Vaccines multidisciplinary development team, ...
François Sallans
François Sallans is Vice President and Chief Quality Officer, Pharmaceuticals, for Johnson & Johnson. He assumed this role in April 2012. In his current role, François manages end-to-end quality for the Pharmaceutical sector, covering Janssen Supply ...
JDRF partnership
Janssen Sets a Course to Intercept Type 1 Diabetes Together with JDRF As part of its disease interception strategy to halt progression of type 1 diabetes (T1D) before the disease manifests, the Disease Interception Accelerator (DIA) began a research ...
Collaboration in Infectious Disease Research
Article Type: Infectious Diseases & Vaccines Our Partners in Infectious Diseases & Vaccines Our innovation is founded by our mission to discover and develop novel therapeutics and vaccines to treat and cure infectious diseases worldwide, ...
Respiratory Infections
Respiratory Infections Article Type: Infectious Diseases & Vaccines By focusing on vulnerable populations, we aim to improve health for everyone across the globe. At Janssen, we have a deep heritage of caring for those affected by respiratory ...